AMINOQUINAZOLINE COMPOUNDS Russian patent published in 2010 - IPC C07D239/95 C07D403/04 C07D403/10 C07D401/12 C07D409/04 C07D413/04 C07D405/12 C07D401/04 A61K31/517 A61P3/08 A61P3/04 A61P3/10 

Abstract RU 2382034 C2

FIELD: chemistry.

SUBSTANCE: invention relates to novel compounds of formula (I) which are protein tyrosine kinase 1B(PTP-1B) inhibitors and can be used in medicinal preparations for treating and preventing diseases related to high concentration of glucose in blood, for example diabetes and obesity. In formula (I) X is a X-1 group or X-2: , where R1 and R2 are each independently selected from a group consisting of hydrogen, lower alkyl, alkoxy-lower alkyl and hydroxyl-lower alkyl, under the condition that, R1 and R2 both represent hydrogen; R3, R4, R6 and R7 are each independently selected from a group consisting of hydrogen, lower alkyl; lower alkyl substituted with halogen or hydroxy; lower alkoxy; lower alkoxy substituted with halogen, hydroxy or lower alkoxy; hydroxyl, halogen, lower alkylthio, lower alkylsufanyl, lower alkylsufanyl, aminosufonyl, cyano, nitro, carbamoyl, lower mono- or dialkylcarbamoyl, lower alkanoyl, benzoyl, phenyl, phenyl substituted with halogen, phenyloxy, lower mono- or dialkylamino, hydroxy-substituted lower alkylamino, lower alkanoylamino, lower alkylsulfonylamino, heterocycloalkyl, hydroxy-substituted heterocycloalkyl, heterocyclyloxy, heterocyclylcarbonyl; where each heterocycloalkyl in the said values represents a 5-6-membr ring containing 1-2 heteroatoms selected from nitrogen and oxygen, and which can be substituted with lower alkyl or phenyl-lower alkyl; carboxyl, lower alkoxycarbonyl and a substitute of formula: ; R8 is selected from a group consisting of hydrogen, lower alkylthio, halogen, alkoxy-lower alkoxy, lower alkoxy, halogen-lower alkyl, hydroxy-lower alkyl; represents a 5-member heteroaromatic ring containing 1 or 2 heteroatoms selected from a group consisting of hydrogen, sulphur and nitrogen; R8 and R9 each independently represents hydrogen or lower alkyl.

EFFECT: novel compounds have useful biological properties.

31 cl, 7 dwg, 152 ex

Similar patents RU2382034C2

Title Year Author Number
DIAMINOPYRROLO QUINAZOLINES DERIVATIVES AS PROTEIN TYROSINE KINASE INHIBITORS 2004
  • Bertel Stiven Dzhozef
  • Chehjun Adrian Vajkhin
  • Kim Kjungchzhin
  • Tkhakkar Kshitij Chkhabilbkhaj
  • Jun' Vehjja
RU2345079C2
QUINAZOLINYLMETHYLENETRIAZOLINONES AS CDK-1 INHIBITORS 2005
  • Chehn' Li
  • Chehn' Shaotszin
  • Lju Tszin'Tszun'
RU2405782C2
DIAMINOPYRROLOQUINAZOLINES DERIVATIVES AS PROTEINTYROSINE PHOSPHATASE INHIBITORS 2004
  • Bertel Stiven Dzhozef
  • Tkhakkar Kshitij Chkhabilbkhaj
RU2367664C2
COMT INHIBITORS 2013
  • Bissants Katerina
  • Bonnafu Rene
  • Byuttelmann Bernd
  • Yakob-Roetne Roland
  • Lerner Kristian
  • Rudolf Markus
RU2642779C2
AMINOPYRIDINE DERIVATIVES AS MODULATORS OF LEUCINE-RICH REPEATED KINASE 2 (LRRK2) 2012
  • Bejker-Glenn Charlz
  • Chembers Mark
  • Chan Brajan K.
  • Chen Khuejfen
  • Estrada Entoni
  • Shor Daniel
  • Svini Zakari
RU2634716C2
2-PHENYLIMIDAZO[1,2-A]PYRIMIDINES AS IMAGING AGENTS 2014
  • Gobbi Luka
  • Knust Khenner
  • Kerner Mattias
  • Muri Diter
RU2665580C2
QUINAZOLINE DERIVATIVE AND PHARMACEUTICAL PREPARATION 2006
  • Okano Masakhiko
  • Ojama Tatsuja
RU2464263C2
CERTAIN CHEMICAL COMPOUNDS, COMPOSITIONS AND METHODS 2014
  • Tsyan Syanpin
  • Chzhu Jong-Lyan
RU2718876C2
METHOD OF WOUND HEALING WITH APPLYING ANTAGONISTS OF A ADENOSINE RECEPTOR 2005
  • Tszen Dehvan'
  • Belardinelli Luis
RU2385322C2
AMINOPYRAZINE DERIVATIVES AND MEDICATIONS 2010
  • Fudzikhara Khidetaka
  • Asaki Tetsuo
  • Khori Katsutosi
  • Naito Kharuna
RU2535217C2

RU 2 382 034 C2

Authors

Bertel Stiven Dzhozef

Chehun Andrian Vajkhin

Tkhakkar Kshitij Chkhabilbkhaj

Jun' Vehjja

Dates

2010-02-20Published

2005-11-02Filed